Home › NDC Lookup › RxCUI directory › RxCUI 1236070

Acetaminophen 21.7 MG/ML / chlorpheniramine maleate 0.13 MG/ML / dextromethorphan hydrobro... — RxCUI 1236070

Name: Acetaminophen 21.7 MG/ML / chlorpheniramine maleate 0.13 MG/ML / dextromethorphan hyd… (RxCUI 1236070)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1236070 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1236070

Official nameAcetaminophen 21.7 MG/ML / chlorpheniramine maleate 0.13 MG/ML / dextromethorphan hydrobromide 0.67 MG/ML Oral Solution

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asAPAP 325 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG per 15 ML Oral Solution; acetaminophen 325 MG / chlorpheniramine maleate 2 MG / dextromethorphan HBr 10 MG in 15 mL Oral Solution; APAP 21.7 MG/ML / Chlorpheniramine Maleate 0.13 MG/ML / Dextromethorphan Hydrobromide 0.67 MG/ML Oral Solution

FDA products mapped1

Package NDCs mapped1

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Acetaminophen Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It treats mild to moderate pain, and moderate to severe pain when used with opioid medicines. It also lowers fever. It is given through a vein in a healthcare setting.
What is Acetaminophen Injection used for?
It is given as an IV infusion over 15 minutes by a healthcare professional. Your dose depends on your age and weight. Your care team follows the label and your prescriber's orders.
The most common are nausea and vomiting. Adults may also get headache or trouble sleeping. Children may have constipation or itching.

📖 Read our full Acetaminophen Injection guide →

🕸️ Concept Web — How Acetaminophen 21.7 MG/ML / chlorpheniramine male... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Acetaminophen 21.7 MG/ML / chlorpheniramine maleate 0.13 MG/ML / dextromethorphan hydrobromide 0.67 MG/ML Oral Solution RxCUI 1236070 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 6

The active substance itself — no strength, form, or brand attached yet.
- Acetaminophen 161 IN
- Chlorpheniramine 2400 IN
- Dextromethorphan 3289 IN
- Acetaminophen / chlorpheniramine / dextromethorphan 1007587 MIN
- Chlorpheniramine maleate 142429 PIN
- Dextromethorphan hydrobromide 102490 PIN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Acetaminophen / chlorpheniramine / dextromethorphan Oral Solution 377029 SCDF
- Acetaminophen / chlorpheniramine maleate / dextromethorphan hydrobromide Oral Solution 2648167 SCDFP
- Acetaminophen / chlorpheniramine / dextromethorphan Oral Liquid Product 1155232 SCDG
- Acetaminophen / chlorpheniramine / dextromethorphan Oral Product 1155233 SCDG
- Acetaminophen / chlorpheniramine maleate / dextromethorphan hydrobromide Oral Liquid Product 2660852 SCDGP
- Acetaminophen / chlorpheniramine maleate / dextromethorphan hydrobromide Oral Product 2659663 SCDGP
- Oral Solution 316968 DF
- Oral Liquid Product 1151137 DFG
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Acetaminophen 21.7 MG/ML 332581 SCDC
- Chlorpheniramine maleate 0.13 MG/ML 1236069 SCDC
- Dextromethorphan hydrobromide 0.67 MG/ML 1098654 SCDC

Showing up to 8 concepts per family — 17 of 18 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Acetaminophen 21.7 MG/ML SCDC · 332581
Chlorpheniramine maleate 0.13 MG/ML SCDC · 1236069
Dextromethorphan hydrobromide 0.67 MG/ML SCDC · 1098654
Acetaminophen / chlorpheniramine / dextromethorphan Oral Solution SCDF · 377029
Acetaminophen / chlorpheniramine maleate / dextromethorphan hydrobromide Oral Solution SCDFP · 2648167
Acetaminophen / chlorpheniramine / dextromethorphan Oral Liquid Product SCDG · 1155232
Acetaminophen / chlorpheniramine / dextromethorphan Oral Product SCDG · 1155233
Acetaminophen / chlorpheniramine maleate / dextromethorphan hydrobromide Oral Liquid Product SCDGP · 2660852
Acetaminophen / chlorpheniramine maleate / dextromethorphan hydrobromide Oral Product SCDGP · 2659663

📦 FDA Products & Package NDCs

1 product · 1 package NDC

1 package NDC map to RxCUI 1236070 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
49873-0108-01	1 BOTTLE in 1 CARTON (49873-108-01) / 120 mL in 1 BOTTLE	Stona for Children	Sato Pharmaceutical Co., Ltd.	2001-01-03

Observed labelers: Sato Pharmaceutical Co., Ltd. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.